Most of the largest pharmaceutical companies report losing money in the United States, despite the majority of their sales coming from Americans. The result is lower U.S. taxes for the companies.

The Treasury secretary is adding her support to a widely discussed proposal as part of the Biden administration's tougher approach to corporate taxes.